Stimcell Energetics (STME) Assets (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Stimcell Energetics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -34.05% |
| Nov 30, 2025 | 219.43% |
| Aug 31, 2025 | -22.78% |
| May 31, 2025 | 24.03% |
| Feb 28, 2025 | -55.38% |
| Nov 30, 2024 | 71.21% |
| Aug 31, 2024 | -51.44% |
| May 31, 2024 | -43.70% |
| Feb 29, 2024 | 257.99% |
| Nov 30, 2023 | -63.28% |
| Aug 31, 2023 | -39.65% |
| May 31, 2023 | 643.16% |
| Feb 28, 2023 | -42.15% |
| Nov 30, 2022 | -15.94% |
| Aug 31, 2022 | -30.88% |
| May 31, 2022 | -24.69% |
| Feb 28, 2022 | -24.35% |
| Nov 30, 2021 | -28.78% |
| Aug 31, 2021 | 95.05% |
| May 31, 2021 | -47.78% |
| Feb 28, 2021 | 2.38% |
| Nov 30, 2020 | -59.04% |
| Aug 31, 2020 | 49.89% |
| May 31, 2020 | -29.12% |
| Feb 29, 2020 | -44.28% |
| Nov 30, 2019 | -10.51% |
| Aug 31, 2019 | 136.33% |
| May 31, 2019 | -14.15% |
| Feb 28, 2019 | 133.26% |
| Nov 30, 2018 | 83.10% |
| Aug 31, 2018 | 14.82% |
| May 31, 2018 | -72.18% |
| Feb 28, 2018 | -56.77% |
| Nov 30, 2017 | -29.30% |
| Aug 31, 2017 | 81.22% |
| May 31, 2017 | -12.32% |
| May 31, 2013 | -12.72% |
| Feb 28, 2013 | -33.48% |
| May 31, 2012 | -21.33% |
| Feb 29, 2012 | 176,470.59% |
| Nov 30, 2011 | 0.00% |
| Aug 31, 2011 | 0.00% |